Clinical Trials Directory

Trials / Completed

CompletedNCT03216954

Influence of n-Acetylcysteine Maintenance on Alcohol Effects

A Human Laboratory Study of n-Acetylcysteine for Alcohol Use Disorder

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
14 (actual)
Sponsor
William Stoops · Academic / Other
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Accepted

Summary

This study will evaluate the behavioral effects of alcohol during placebo and n-acetylcysteine maintenance using sophisticated human laboratory methods.

Conditions

Interventions

TypeNameDescription
DRUGAlcoholDuring each arm, subjects will receive doses of alcohol, designed to raise BALs to 0.015 and 0.03 g/dl.
DRUGPlacebosSubjects will receive placebo capsules
DRUGN-acetyl cysteineSubjects will receive n-acetyl cysteine capsules

Timeline

Start date
2017-09-15
Primary completion
2020-04-23
Completion
2020-04-23
First posted
2017-07-13
Last updated
2021-01-26
Results posted
2021-01-26

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03216954. Inclusion in this directory is not an endorsement.

Influence of n-Acetylcysteine Maintenance on Alcohol Effects (NCT03216954) · Clinical Trials Directory